A23L27/204

FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES

The present application relates to bicyclo[2.2.1]heptane and bicyclo[2.2.1]heptene derivatives, methods of making them, and methods of using them as flavor and fragrance ingredients in food, cosmetic, pharmaceutical, consumer, and other compositions and products.

FLAVORING COMPOSITIONS HAVING A ROAST AROMA PROFILE
20260090576 · 2026-04-02 · ·

The present disclosure relates generally to flavoring compositions having a roast aroma profile and their use in flavored consumer products. In certain aspects, the disclosure also provides methods for the preparation of such flavoring compositions.

ORAL COMPOSITION
20260096585 · 2026-04-09 · ·

A solid oral composition, including: (A) 0.00005 mass ppm to 40 mass ppm of a branched fatty acid, (B) pyrazines, and (C) 4-vinylguaiacol. A mass ratio of the component (B) to the component (A), [(B)/(A)], is 0.015 or more. a mass ratio of the component (B) to a total amount of the component (A) and the component (C), [(B)/[(A)+(C)]], is 0.01 or more. The branched fatty acid may be isobutyric acid, 2-methylbutyric acid, or isovaleric acid.

APIGENIN GLYCOSIDES FLAVOR ENHANCERS
20260101915 · 2026-04-16 ·

Disclosed herein are compounds and methods useful for improving the flavor and suppressing bitter sensations is a variety of food products, including cereals and grains such as wheat.

VANILLA COMPOSITION

Described herein is a composition for conferring, enhancing, or imparting a vanilla note, the composition including 2-hydroxy-4-methoxybenzaldehyde and vanillin imparted compound selected from the group of 3-methoxy-4-hydroxybenzaldehyde or 4-hydroxy-3-ethoxybenzaldehyde. Also described herein is a perfumed or flavored consumer product including this composition. Moreover, described are an extract including at least 10% of 2-hydroxy-4-methoxybenzaldehyde, and a method to improve, enhance, or modify the vanilla flavour profile of a composition using such an extract.

ORAL COMPOSITION
20260107962 · 2026-04-23 · ·

An oral composition, including the following components (A), (B), and (C): (A) 10 mass % to 20 mass % of a chlorogenic acid; (B) 0.4 mass % to 5 mass % of caffeine; and (C) 4-vinylguaiacol. A mass ratio of the component (C) to the component (B), [(C)/(B)], is 0.310.sup.4 or more and 3010.sup.4 or less.